We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,050 results
  1. Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1

    Background

    The development of multidrug resistance (MDR) associated with the overexpression of the efflux transporters Mdr1 and Cdr1 in Candida ...

    Florimar Gil, Jerónimo Laiolo, ... María Cecilia Carpinella in BMC Complementary Medicine and Therapies
    Article Open access 12 October 2022
  2. Polymorphic renal transporters and cisplatin’s toxicity in urinary bladder cancer patients: current perspectives and future directions

    Urinary bladder cancer (UBC) holds a potentially profound social burden and affects over 573,278 new cases annually. The disease’s primary risk...

    Mohamed S. Selim, Amira B. Kassem, ... Marwa Samir Hamza in Medical Oncology
    Article Open access 17 January 2023
  3. Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters

    Virtually all neuropsychiatric disorders display sex differences in prevalence, age of onset, and/or clinical symptomology. Although altered dopamine...

    Adele Stewart, Felix P. Mayer, ... Randy D. Blakely in Molecular Psychiatry
    Article 18 September 2022
  4. Nutrient transporters: connecting cancer metabolism to therapeutic opportunities

    Cancer cells rely on certain extracellular nutrients to sustain their metabolism and growth. Solute carrier (SLC) transporters enable cells to...

    Zeribe Chike Nwosu, Mun Gu Song, ... Sung Eun Kim in Oncogene
    Article 04 February 2023
  5. Combination of mangiferin and T0901317 targeting autophagy promotes cholesterol efflux from macrophage foam cell in atherosclerosis

    Background

    The synthetic liver X receptor ligand (LXR) T0901317 (T0) has been reported to attenuate atherosclerosis (AS) without hyperglyceridemia due...

    Qian Chen, Sijian Wang, ... Tao Wang in Chinese Medicine
    Article Open access 05 January 2024
  6. Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

    The renal secretion of many drugs is facilitated by membrane transporters, including organic cation transporter 2, multidrug and toxin extrusion...

    Hee Jae Choi, Shilpa Madari, Fenglei Huang in Clinical Pharmacokinetics
    Article Open access 13 June 2024
  7. New uracil analog as inhibitor/modulator of ABC transporters or/and NF-κB in taxol-resistant MCF-7/Tx cell line

    Purpose

    The global increase in breast cancer cases necessitates ongoing exploration of advanced therapies. Taxol (Tx), an initial breast cancer...

    Angelika Długosz-Pokorska, Tomasz Janecki, ... Katarzyna Gach-Janczak in Journal of Cancer Research and Clinical Oncology
    Article Open access 25 June 2024
  8. Blocking of efflux transporters in rats improves translational validation of brain radioligands

    Background

    Positron emission tomography (PET) is a molecular imaging technique that can be used to investigate the in vivo pharmacology of drugs....

    Vladimir Shalgunov, Mengfei **ong, ... Matthias M. Herth in EJNMMI Research
    Article Open access 19 October 2020
  9. Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions

    By clearing GABA from the synaptic cleft, GABA transporters (GATs) play an essential role in inhibitory neurotransmission. Consequently, in vivo...

    Niels Knippenberg, Matthias Bauwens, ... Hanne Diliën in EJNMMI Research
    Article Open access 12 May 2023
  10. Zinc transporters ZIPT-2.4 and ZIPT-15 are required for normal C. elegans fecundity

    Purpose

    The requirement of zinc for the development and maturation of germ lines and reproductive systems is deeply conserved across evolution. The...

    Aaron C. Sue, Sarah M. Wignall, ... Thomas V. O’Halloran in Journal of Assisted Reproduction and Genetics
    Article 01 May 2022
  11. Inhibition of the uric acid efflux transporter ABCG2 enhances stimulating effect of soluble uric acid on IL-1β production in murine macrophage-like J774.1 cells

    Soluble uric acid (UA) absorbed by cells through UA transporters (UATs) accumulates intracellularly, activates the NLRP3 inflammasome and thereby...

    Tomomi Notsu, Yasutaka Kurata, ... Ichiro Hisatome in Hypertension Research
    Article 17 August 2023
  12. Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process

    Pendred syndrome (PDS) is an autosomal recessive disorder caused by mutations in the gene that encodes pendrin. Pendred thyroid tissue is supposedly...

    V. Vázquez-Román, J. M. Cameselle-Teijeiro, ... I. Martín-Lacave in Endocrine Pathology
    Article Open access 15 October 2022
  13. The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated efflux

    Neratinib, an irreversible pan-HER tyrosine kinase inhibitor, has been approved for the treatment of HER2-positive (HER2 + ) early-stage and brain...

    Defei Qi, Yuanyuan Dou, ... Hua Sun in Investigational New Drugs
    Article 04 November 2022
  14. HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control

    Background

    Reduced cholesterol efflux capacity (CEC) of HDLs is likely to increase cardiovascular risk in type 1 diabetes (T1D). We aimed to assess...

    Damien Denimal, Serge Monier, ... Benjamin Bouillet in Cardiovascular Diabetology
    Article Open access 12 August 2022
  15. Luteolin increases susceptibility to macrolides by inhibiting MsrA efflux pump in Trueperella pyogenes

    Trueperella pyogenes ( T. pyogenes ) is an opportunistic pathogen associated with a variety of diseases in many domestic animals. Therapeutic treatment...

    Yuru Guo, Chengcheng Huang, ... Mingchun Liu in Veterinary Research
    Article Open access 10 January 2022
  16. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents

    The treatment of patients infected with the hepatitis C virus (HCV) has been revolutionised by the development of direct-acting antiviral agents...

    Michael Murray in Clinical Pharmacokinetics
    Article 20 September 2023
  17. Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic–pharmacokinetic and exposure–response analysis

    Purpose

    Because of the large interindividual variability of afatinib pharmacokinetics and adverse events, we evaluated the effects of polymorphisms in...

    Hayato Yokota, Kazuhiro Sato, ... Masatomo Miura in Cancer Chemotherapy and Pharmacology
    Article 27 July 2023
  18. Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells

    Purpose

    Drug efflux transporter associated multi-drug resistance (MDR) is a potential limitation in the use of taxane chemotherapies for the treatment...

    Thamir M. Mahgoub, Emmet J. Jordan, ... Denis M. Collins in Cancer Chemotherapy and Pharmacology
    Article Open access 16 January 2024
  19. Strategies to Combat Bacterial Antimicrobial Resistance: a Focus on Mechanism of the Efflux Pumps Inhibitors

    The surge in multidrug resistance (MDR) in the bacterial system has constricted the use of foregoing therapeutics for the treatment of fatal...

    Privita Verma, Monalisa Tiwari, Vishvanath Tiwari in SN Comprehensive Clinical Medicine
    Article 05 February 2021
  20. Prediction of drug–drug interaction potential mediated by transporters between dasatinib and metformin, pravastatin, and rosuvastatin using physiologically based pharmacokinetic modeling

    Purpose

    Recent in vitro studies demonstrated that dasatinib inhibits organic cation transporter 2 (OCT2), multidrug and toxin extrusion proteins...

    Ming Chang, Sai Bathena, ... Amit Roy in Cancer Chemotherapy and Pharmacology
    Article Open access 11 February 2022
Did you find what you were looking for? Share feedback.